- Orlistat in the long-term treatment of obesity in primary care settingsJ Hauptman
Department of International Clinical Research, Hoffman LaRoche Inc, Nutley, NJ 07110, USA
Arch Fam Med 9:160-7. 2000..To evaluate the long-term efficacy and tolerability within primary care settings of orlistat, a gastrointestinal lipase inhibitor, for the treatment of obesity...
- Orlistat: selective inhibition of caloric absorption can affect long-term body weightJ Hauptman
Hoffmann La Roche Inc, Nutley, NJ 07110 1199, USA
Endocrine 13:201-6. 2000..Orlistat acts locally in the gastrointestinal tract and is only minimally absorbed. In long-term clinical trials, orlistat was well tolerated by both diabetic and nondiabetic subjects...